IRCT20200510047385N1
Recruiting
Phase 2
Effect of stromal vascular fraction (SVF), blood and condition medium derived exosomes on treatment of covid-19 patients with Acute Respiratory Distress Syndrome(ARDS)/ clinical Trial
ConditionsCovid19.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Covid19.
- Sponsor
- Tabriz University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •covid19 patients hospitalized in the ICU, which includes all confirmatory tests –
- •Satisfaction in studying
Exclusion Criteria
- •History of kidney transplantation
- •History surgery on the lungs
- •The presence of any malignancy
- •Previous active infection
- •Use immunosuppressive and other drugs
- •The presence of autoimmune disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparative, double arm, non-randomized study for Androgenetic AlopeciaCTRI/2022/04/042206A10
Completed
Not Applicable
Mesenchymal stem Cell application in diabetic wound healingDiabetic wound.Diabetes mellitusE10,E14IRCT2015110224834N1Vice Chancellor for research of Kashan University of Medical Sciences,10
Not yet recruiting
Phase 1
Clinical Treatment of Acute and Chronic Wounds using Autologous Stromal Vascular Fraction Isolated from LipoaspirateChronic venous ulcerSkin - Other skin conditionsCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12613001332718Royal Adelaide Hospital60
Recruiting
Phase 3
Human stromal vascular fraction(SVF) and platelet-rich plasma(PRP) in treatment of therapy-resistant diabetic foot ulcersIRCT20130811014330N9Mashhad University of Medical Sciences20
Unknown
Phase 1
Effect of SVF Derived MSC in DCD Renal TransplantationUremiaNCT02492490Fuzhou General Hospital120